These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 19052552

  • 1. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
    DeCastro M, El-Khoury N, Parton L, Ballabh P, LaGamma EF.
    J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 3. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, DART Study Investigators.
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
    Rozycki HJ, Byron PR, Elliott GR, Carroll T, Gutcher GR.
    Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
    [Abstract] [Full Text] [Related]

  • 5. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.
    Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK.
    N Engl J Med; 1998 Apr 16; 338(16):1112-8. PubMed ID: 9545359
    [Abstract] [Full Text] [Related]

  • 6. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH, Fayon M, Baud O, Autret-Leca E, Danan M, de Verdelhan A, Castot A.
    Arch Pediatr; 2010 Oct 16; 17(10):1480-7. PubMed ID: 20864322
    [Abstract] [Full Text] [Related]

  • 7. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes.
    Peaceman AM, Bajaj K, Kumar P, Grobman WA.
    Am J Obstet Gynecol; 2005 Sep 16; 193(3 Pt 2):1165-9. PubMed ID: 16157131
    [Abstract] [Full Text] [Related]

  • 8. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO, Anstead MI, Shook LA.
    Respir Res; 2007 Jun 05; 8(1):41. PubMed ID: 17550598
    [Abstract] [Full Text] [Related]

  • 9. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ, Brans YW, Poland RL.
    Pediatrics; 1990 Nov 05; 86(5):722-7. PubMed ID: 2235226
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of corticosteroids on lung function and the clinical course of bronchopulmonary dysplasia in premature infants with a birth weight below 1,500 g].
    Hanssler L, Zhou C, Roll C, Wiesemann HG.
    Klin Padiatr; 1994 Nov 05; 206(5):372-6. PubMed ID: 7799612
    [Abstract] [Full Text] [Related]

  • 12. Short-term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone.
    Bar-Lev MR, Maayan-Metzger A, Matok I, Heyman Z, Sivan E, Kuint J.
    Obstet Gynecol; 2004 Sep 05; 104(3):484-8. PubMed ID: 15339757
    [Abstract] [Full Text] [Related]

  • 13. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J, Beedgen B, Böhler T, Sontheimer D, Zilow EP, Linderkamp O.
    Klin Padiatr; 1996 Sep 05; 208(2):56-60. PubMed ID: 8901183
    [Abstract] [Full Text] [Related]

  • 14. Effect of prolonged dexamethasone on oxygen-dependency in infants with chronic lung disease.
    Zanardo V, Trevisanuto D, Vanin E, Marzari F, Guglielmi A.
    Pediatr Med Chir; 1999 Sep 05; 21(1):1-4. PubMed ID: 10451887
    [Abstract] [Full Text] [Related]

  • 15. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar 05; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 16. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
    Feldman DM, Carbone J, Belden L, Borgida AF, Herson V.
    Am J Obstet Gynecol; 2007 Sep 05; 197(3):284.e1-4. PubMed ID: 17826422
    [Abstract] [Full Text] [Related]

  • 17. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
    Forest S.
    J Perinat Neonatal Nurs; 2011 Sep 05; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone.
    Alkalay AL, Pomerance JJ, Puri AR, Lin BJ, Vinstein AL, Neufeld ND, Klein AH.
    Pediatrics; 1990 Aug 05; 86(2):204-10. PubMed ID: 2371095
    [Abstract] [Full Text] [Related]

  • 19. Total steroid dose given to ventilated newborn infants with chronic lung disease.
    Jones BO, Davies MW.
    J Paediatr Child Health; 2007 Aug 05; 43(1-2):40-3. PubMed ID: 17207054
    [Abstract] [Full Text] [Related]

  • 20. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.
    Yates HL, Newell SJ.
    Arch Dis Child Fetal Neonatal Ed; 2011 May 05; 96(3):F190-4. PubMed ID: 21115554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.